Cencora Inc., US15135B1017

Cencora stock holds firm as analysts keep a $370.85 target

Published on 08/27/2026 at 12:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cencora stock is trading near $327.94 as analysts keep a $370.85 target and the shares sit between a $244.82 low and a $377.54 high.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks
Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora Inc. (US15135B1017) is trading at $327.94, with a 52-week range of $244.82 to $377.54 and a market capitalization of $62.58 billion as of August 27, 2026.

MarketBeat said the stock opened at $327.94 on Thursday and cited an average rating of Moderate Buy with a consensus target price of $370.85, while the latest trading snapshot showed a 0.57 beta and a price-to-earnings ratio of 24.36.

Street view stays constructive

The same snapshot also put Cencora's 50-day moving average at $305.39 and its 200-day moving average at $311.07, leaving the shares above both trend gauges and inside the upper half of the yearly range.

That setup matters because the stock is already trading more than $17 below the consensus target price and $49.60 below the 52-week high of $377.54, which leaves valuation and momentum both in view.

Recent ownership moves

A fresh filing item tracked by MarketBeat said PDT Partners LLC invested $1.06 million in Cencora, while another filing item reported Freestone Grove Partners LP buying $41.20 million worth of shares and Caisse de depot et placement du Quebec acquiring 914,234 shares valued at $258.71 million.

Separately, an insider-sale item dated August 24, 2026 said EVP Elizabeth S. Campbell sold 11,300 shares at $324.12 for $3.66 million, a price that sits below the current quote and above the 50-day average.

More on Cencora's model

Cencora's distribution business spans pharmaceutical sourcing, specialty logistics, and related services for healthcare manufacturers and providers, a model that tends to keep revenue tied to volume and contract flow rather than a single product cycle.

Shares and setup

The stock ended at $327.94 on August 27, 2026, with the market value at $62.58 billion and the 52-week band still spanning $244.82 to $377.54.

Company

Company: Cencora Inc.

ISIN: US15135B1017

Ticker: COR

Exchange: NYSE

Price (as of August 27, 2026): $327.94 USD

Market cap: $62.58 billion

Sector / Industry: Health Care / Healthcare Distributors

Index membership: S&P 500

Go deeper

Investor Relations

Disclaimer...

en | US15135B1017 | CENCORA INC. | boerse | 70008080 | bgmi